nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS6—skin of body—systemic scleroderma	0.00459	0.00985	CbGeAlD
Metformin—NDUFA1—connective tissue—systemic scleroderma	0.00408	0.00875	CbGeAlD
Metformin—NDUFV2—connective tissue—systemic scleroderma	0.00396	0.0085	CbGeAlD
Metformin—NDUFA13—skin of body—systemic scleroderma	0.00374	0.00803	CbGeAlD
Metformin—NDUFA9—skin of body—systemic scleroderma	0.00374	0.00803	CbGeAlD
Metformin—NDUFS6—digestive system—systemic scleroderma	0.00367	0.00788	CbGeAlD
Metformin—NDUFA7—tendon—systemic scleroderma	0.00341	0.00731	CbGeAlD
Metformin—NDUFAF3—digestive system—systemic scleroderma	0.00334	0.00717	CbGeAlD
Metformin—ND4L—smooth muscle tissue—systemic scleroderma	0.00332	0.00711	CbGeAlD
Metformin—ND3—smooth muscle tissue—systemic scleroderma	0.00332	0.00711	CbGeAlD
Metformin—ND5—smooth muscle tissue—systemic scleroderma	0.00332	0.00711	CbGeAlD
Metformin—ND2—smooth muscle tissue—systemic scleroderma	0.00332	0.00711	CbGeAlD
Metformin—ND4L—skin of body—systemic scleroderma	0.00327	0.00702	CbGeAlD
Metformin—ND3—skin of body—systemic scleroderma	0.00327	0.00702	CbGeAlD
Metformin—ND2—skin of body—systemic scleroderma	0.00327	0.00702	CbGeAlD
Metformin—ND5—skin of body—systemic scleroderma	0.00327	0.00702	CbGeAlD
Metformin—ND4—smooth muscle tissue—systemic scleroderma	0.00321	0.00688	CbGeAlD
Metformin—ND4—skin of body—systemic scleroderma	0.00317	0.00679	CbGeAlD
Metformin—NDUFA2—smooth muscle tissue—systemic scleroderma	0.00314	0.00674	CbGeAlD
Metformin—NDUFA5—connective tissue—systemic scleroderma	0.00307	0.00658	CbGeAlD
Metformin—NDUFS6—lung—systemic scleroderma	0.00307	0.00658	CbGeAlD
Metformin—NDUFAF4—connective tissue—systemic scleroderma	0.00305	0.00654	CbGeAlD
Metformin—NDUFS1—connective tissue—systemic scleroderma	0.00303	0.00649	CbGeAlD
Metformin—NDUFB10—connective tissue—systemic scleroderma	0.003	0.00644	CbGeAlD
Metformin—NDUFA10—smooth muscle tissue—systemic scleroderma	0.003	0.00643	CbGeAlD
Metformin—NDUFA9—digestive system—systemic scleroderma	0.003	0.00642	CbGeAlD
Metformin—NDUFA13—digestive system—systemic scleroderma	0.003	0.00642	CbGeAlD
Metformin—NDUFA7—lung—systemic scleroderma	0.00299	0.00641	CbGeAlD
Metformin—NDUFC1—smooth muscle tissue—systemic scleroderma	0.00297	0.00637	CbGeAlD
Metformin—NDUFA10—skin of body—systemic scleroderma	0.00296	0.00635	CbGeAlD
Metformin—NDUFA1—digestive system—systemic scleroderma	0.00295	0.00632	CbGeAlD
Metformin—NDUFB2—smooth muscle tissue—systemic scleroderma	0.00295	0.00632	CbGeAlD
Metformin—NDUFC1—skin of body—systemic scleroderma	0.00293	0.00629	CbGeAlD
Metformin—NDUFA6—connective tissue—systemic scleroderma	0.00292	0.00627	CbGeAlD
Metformin—NDUFS4—connective tissue—systemic scleroderma	0.0029	0.00622	CbGeAlD
Metformin—ND6—smooth muscle tissue—systemic scleroderma	0.0029	0.00622	CbGeAlD
Metformin—NDUFB3—smooth muscle tissue—systemic scleroderma	0.00287	0.00617	CbGeAlD
Metformin—NDUFB4—connective tissue—systemic scleroderma	0.00287	0.00614	CbGeAlD
Metformin—NDUFV2—digestive system—systemic scleroderma	0.00286	0.00614	CbGeAlD
Metformin—ND6—skin of body—systemic scleroderma	0.00286	0.00614	CbGeAlD
Metformin—NDUFAB1—connective tissue—systemic scleroderma	0.00285	0.00611	CbGeAlD
Metformin—NDUFB9—connective tissue—systemic scleroderma	0.00283	0.00607	CbGeAlD
Metformin—NDUFV1—connective tissue—systemic scleroderma	0.0028	0.006	CbGeAlD
Metformin—NDUFAF3—lung—systemic scleroderma	0.00279	0.00599	CbGeAlD
Metformin—NDUFB6—smooth muscle tissue—systemic scleroderma	0.00279	0.00598	CbGeAlD
Metformin—NDUFS5—connective tissue—systemic scleroderma	0.00278	0.00596	CbGeAlD
Metformin—NDUFB8—connective tissue—systemic scleroderma	0.00278	0.00596	CbGeAlD
Metformin—NDUFA5—skin of body—systemic scleroderma	0.00277	0.00595	CbGeAlD
Metformin—NDUFS1—smooth muscle tissue—systemic scleroderma	0.00277	0.00593	CbGeAlD
Metformin—NDUFB6—skin of body—systemic scleroderma	0.00275	0.0059	CbGeAlD
Metformin—NDUFS1—skin of body—systemic scleroderma	0.00273	0.00586	CbGeAlD
Metformin—NDUFB7—smooth muscle tissue—systemic scleroderma	0.00273	0.00585	CbGeAlD
Metformin—NDUFA12—smooth muscle tissue—systemic scleroderma	0.00273	0.00585	CbGeAlD
Metformin—NDUFB10—skin of body—systemic scleroderma	0.00271	0.00582	CbGeAlD
Metformin—NDUFB1—smooth muscle tissue—systemic scleroderma	0.00271	0.00581	CbGeAlD
Metformin—NDUFS8—smooth muscle tissue—systemic scleroderma	0.00271	0.00581	CbGeAlD
Metformin—NDUFB5—smooth muscle tissue—systemic scleroderma	0.00267	0.00573	CbGeAlD
Metformin—NDUFA6—smooth muscle tissue—systemic scleroderma	0.00267	0.00573	CbGeAlD
Metformin—NDUFS4—smooth muscle tissue—systemic scleroderma	0.00266	0.00569	CbGeAlD
Metformin—NDUFA4L2—tendon—systemic scleroderma	0.00265	0.00568	CbGeAlD
Metformin—NDUFB5—skin of body—systemic scleroderma	0.00264	0.00566	CbGeAlD
Metformin—NDUFB4—smooth muscle tissue—systemic scleroderma	0.00262	0.00562	CbGeAlD
Metformin—ND3—digestive system—systemic scleroderma	0.00262	0.00561	CbGeAlD
Metformin—ND2—digestive system—systemic scleroderma	0.00262	0.00561	CbGeAlD
Metformin—ND5—digestive system—systemic scleroderma	0.00262	0.00561	CbGeAlD
Metformin—ND4L—digestive system—systemic scleroderma	0.00262	0.00561	CbGeAlD
Metformin—NDUFAB1—smooth muscle tissue—systemic scleroderma	0.0026	0.00559	CbGeAlD
Metformin—NDUFS7—connective tissue—systemic scleroderma	0.0026	0.00558	CbGeAlD
Metformin—NDUFA8—smooth muscle tissue—systemic scleroderma	0.00259	0.00555	CbGeAlD
Metformin—NDUFB9—smooth muscle tissue—systemic scleroderma	0.00259	0.00555	CbGeAlD
Metformin—NDUFA4—smooth muscle tissue—systemic scleroderma	0.00257	0.00552	CbGeAlD
Metformin—NDUFAB1—skin of body—systemic scleroderma	0.00257	0.00551	CbGeAlD
Metformin—NDUFB11—smooth muscle tissue—systemic scleroderma	0.00256	0.00548	CbGeAlD
Metformin—NDUFV1—smooth muscle tissue—systemic scleroderma	0.00256	0.00548	CbGeAlD
Metformin—NDUFB9—skin of body—systemic scleroderma	0.00256	0.00548	CbGeAlD
Metformin—NDUFS5—smooth muscle tissue—systemic scleroderma	0.00254	0.00545	CbGeAlD
Metformin—NDUFB8—smooth muscle tissue—systemic scleroderma	0.00254	0.00545	CbGeAlD
Metformin—NDUFA4—skin of body—systemic scleroderma	0.00254	0.00545	CbGeAlD
Metformin—ND4—digestive system—systemic scleroderma	0.00253	0.00543	CbGeAlD
Metformin—NDUFV1—skin of body—systemic scleroderma	0.00252	0.00541	CbGeAlD
Metformin—NDUFS5—skin of body—systemic scleroderma	0.00251	0.00538	CbGeAlD
Metformin—NDUFB8—skin of body—systemic scleroderma	0.00251	0.00538	CbGeAlD
Metformin—NDUFA9—lung—systemic scleroderma	0.0025	0.00536	CbGeAlD
Metformin—NDUFA13—lung—systemic scleroderma	0.0025	0.00536	CbGeAlD
Metformin—NDUFA1—lung—systemic scleroderma	0.00246	0.00528	CbGeAlD
Metformin—NDUFV2—lung—systemic scleroderma	0.00239	0.00513	CbGeAlD
Metformin—NDUFA10—digestive system—systemic scleroderma	0.00237	0.00508	CbGeAlD
Metformin—NDUFA2—tendon—systemic scleroderma	0.00236	0.00507	CbGeAlD
Metformin—NDUFB2—digestive system—systemic scleroderma	0.00233	0.00499	CbGeAlD
Metformin—NDUFA4L2—lung—systemic scleroderma	0.00233	0.00499	CbGeAlD
Metformin—ND6—digestive system—systemic scleroderma	0.00229	0.00491	CbGeAlD
Metformin—NDUFA10—tendon—systemic scleroderma	0.00225	0.00483	CbGeAlD
Metformin—NDUFC1—tendon—systemic scleroderma	0.00223	0.00479	CbGeAlD
Metformin—NDUFA5—digestive system—systemic scleroderma	0.00222	0.00476	CbGeAlD
Metformin—NDUFB2—tendon—systemic scleroderma	0.00221	0.00475	CbGeAlD
Metformin—NDUFAF1—tendon—systemic scleroderma	0.0022	0.00471	CbGeAlD
Metformin—ND3—lung—systemic scleroderma	0.00219	0.00469	CbGeAlD
Metformin—ND2—lung—systemic scleroderma	0.00219	0.00469	CbGeAlD
Metformin—ND5—lung—systemic scleroderma	0.00219	0.00469	CbGeAlD
Metformin—ND4L—lung—systemic scleroderma	0.00219	0.00469	CbGeAlD
Metformin—NDUFS1—digestive system—systemic scleroderma	0.00218	0.00469	CbGeAlD
Metformin—NDUFB10—digestive system—systemic scleroderma	0.00217	0.00465	CbGeAlD
Metformin—NDUFAF2—tendon—systemic scleroderma	0.00216	0.00463	CbGeAlD
Metformin—NDUFB3—tendon—systemic scleroderma	0.00216	0.00463	CbGeAlD
Metformin—NDUFS2—connective tissue—systemic scleroderma	0.00216	0.00463	CbGeAlD
Metformin—NDUFB7—digestive system—systemic scleroderma	0.00215	0.00462	CbGeAlD
Metformin—NDUFB1—digestive system—systemic scleroderma	0.00214	0.00459	CbGeAlD
Metformin—NDUFS8—digestive system—systemic scleroderma	0.00214	0.00459	CbGeAlD
Metformin—NDUFS3—connective tissue—systemic scleroderma	0.00213	0.00457	CbGeAlD
Metformin—ND4—lung—systemic scleroderma	0.00212	0.00454	CbGeAlD
Metformin—NDUFA11—tendon—systemic scleroderma	0.00211	0.00453	CbGeAlD
Metformin—NDUFA6—digestive system—systemic scleroderma	0.00211	0.00453	CbGeAlD
Metformin—NDUFB5—digestive system—systemic scleroderma	0.00211	0.00453	CbGeAlD
Metformin—NDUFS4—digestive system—systemic scleroderma	0.0021	0.0045	CbGeAlD
Metformin—NDUFAF4—tendon—systemic scleroderma	0.00209	0.00449	CbGeAlD
Metformin—NDUFB6—tendon—systemic scleroderma	0.00209	0.00449	CbGeAlD
Metformin—NDUFS1—tendon—systemic scleroderma	0.00208	0.00446	CbGeAlD
Metformin—NDUFA2—lung—systemic scleroderma	0.00207	0.00445	CbGeAlD
Metformin—NDUFB4—digestive system—systemic scleroderma	0.00207	0.00444	CbGeAlD
Metformin—NDUFB10—tendon—systemic scleroderma	0.00206	0.00443	CbGeAlD
Metformin—NDUFAB1—digestive system—systemic scleroderma	0.00206	0.00441	CbGeAlD
Metformin—NDUFA12—tendon—systemic scleroderma	0.00205	0.0044	CbGeAlD
Metformin—NDUFB7—tendon—systemic scleroderma	0.00205	0.0044	CbGeAlD
Metformin—NDUFB9—digestive system—systemic scleroderma	0.00204	0.00438	CbGeAlD
Metformin—NDUFA8—digestive system—systemic scleroderma	0.00204	0.00438	CbGeAlD
Metformin—NDUFS8—tendon—systemic scleroderma	0.00204	0.00437	CbGeAlD
Metformin—NDUFB1—tendon—systemic scleroderma	0.00204	0.00437	CbGeAlD
Metformin—NDUFA4—digestive system—systemic scleroderma	0.00203	0.00436	CbGeAlD
Metformin—NDUFB11—digestive system—systemic scleroderma	0.00202	0.00433	CbGeAlD
Metformin—NDUFV1—digestive system—systemic scleroderma	0.00202	0.00433	CbGeAlD
Metformin—NDUFB5—tendon—systemic scleroderma	0.00201	0.00431	CbGeAlD
Metformin—NDUFA6—tendon—systemic scleroderma	0.00201	0.00431	CbGeAlD
Metformin—NDUFS5—digestive system—systemic scleroderma	0.00201	0.0043	CbGeAlD
Metformin—NDUFB8—digestive system—systemic scleroderma	0.00201	0.0043	CbGeAlD
Metformin—NDUFS4—tendon—systemic scleroderma	0.002	0.00428	CbGeAlD
Metformin—NDUFA10—lung—systemic scleroderma	0.00198	0.00424	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—systemic scleroderma	0.00197	0.00423	CbGeAlD
Metformin—NDUFB4—tendon—systemic scleroderma	0.00197	0.00422	CbGeAlD
Metformin—NDUFC1—lung—systemic scleroderma	0.00196	0.0042	CbGeAlD
Metformin—NDUFAB1—tendon—systemic scleroderma	0.00196	0.0042	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—systemic scleroderma	0.00195	0.00418	CbGeAlD
Metformin—NDUFS2—skin of body—systemic scleroderma	0.00195	0.00418	CbGeAlD
Metformin—NDUFA8—tendon—systemic scleroderma	0.00194	0.00417	CbGeAlD
Metformin—NDUFB9—tendon—systemic scleroderma	0.00194	0.00417	CbGeAlD
Metformin—NDUFB2—lung—systemic scleroderma	0.00194	0.00417	CbGeAlD
Metformin—NDUFA4—tendon—systemic scleroderma	0.00193	0.00415	CbGeAlD
Metformin—NDUFAF1—lung—systemic scleroderma	0.00193	0.00413	CbGeAlD
Metformin—NDUFS3—skin of body—systemic scleroderma	0.00192	0.00413	CbGeAlD
Metformin—NDUFV1—tendon—systemic scleroderma	0.00192	0.00412	CbGeAlD
Metformin—NDUFB11—tendon—systemic scleroderma	0.00192	0.00412	CbGeAlD
Metformin—ND6—lung—systemic scleroderma	0.00191	0.0041	CbGeAlD
Metformin—NDUFS5—tendon—systemic scleroderma	0.00191	0.0041	CbGeAlD
Metformin—NDUFB8—tendon—systemic scleroderma	0.00191	0.0041	CbGeAlD
Metformin—NDUFAF2—lung—systemic scleroderma	0.0019	0.00407	CbGeAlD
Metformin—NDUFB3—lung—systemic scleroderma	0.0019	0.00407	CbGeAlD
Metformin—NDUFS7—digestive system—systemic scleroderma	0.00188	0.00403	CbGeAlD
Metformin—NDUFA5—lung—systemic scleroderma	0.00185	0.00397	CbGeAlD
Metformin—NDUFA11—lung—systemic scleroderma	0.00185	0.00397	CbGeAlD
Metformin—NDUFB6—lung—systemic scleroderma	0.00184	0.00394	CbGeAlD
Metformin—NDUFAF4—lung—systemic scleroderma	0.00184	0.00394	CbGeAlD
Metformin—NDUFS1—lung—systemic scleroderma	0.00182	0.00391	CbGeAlD
Metformin—NDUFB10—lung—systemic scleroderma	0.00181	0.00389	CbGeAlD
Metformin—NDUFA12—lung—systemic scleroderma	0.0018	0.00386	CbGeAlD
Metformin—NDUFB7—lung—systemic scleroderma	0.0018	0.00386	CbGeAlD
Metformin—NDUFS7—tendon—systemic scleroderma	0.00179	0.00384	CbGeAlD
Metformin—NDUFS8—lung—systemic scleroderma	0.00179	0.00383	CbGeAlD
Metformin—NDUFB1—lung—systemic scleroderma	0.00179	0.00383	CbGeAlD
Metformin—NDUFB5—lung—systemic scleroderma	0.00176	0.00378	CbGeAlD
Metformin—NDUFA6—lung—systemic scleroderma	0.00176	0.00378	CbGeAlD
Metformin—NDUFS4—lung—systemic scleroderma	0.00175	0.00375	CbGeAlD
Metformin—NDUFB4—lung—systemic scleroderma	0.00173	0.00371	CbGeAlD
Metformin—PRKAB1—digestive system—systemic scleroderma	0.00172	0.00369	CbGeAlD
Metformin—NDUFAB1—lung—systemic scleroderma	0.00172	0.00368	CbGeAlD
Metformin—NDUFB9—lung—systemic scleroderma	0.00171	0.00366	CbGeAlD
Metformin—NDUFA8—lung—systemic scleroderma	0.00171	0.00366	CbGeAlD
Metformin—NDUFA4—lung—systemic scleroderma	0.0017	0.00364	CbGeAlD
Metformin—NDUFB11—lung—systemic scleroderma	0.00169	0.00362	CbGeAlD
Metformin—NDUFV1—lung—systemic scleroderma	0.00169	0.00362	CbGeAlD
Metformin—NDUFS5—lung—systemic scleroderma	0.00168	0.0036	CbGeAlD
Metformin—NDUFB8—lung—systemic scleroderma	0.00168	0.0036	CbGeAlD
Metformin—PRKAB1—tendon—systemic scleroderma	0.00164	0.00351	CbGeAlD
Metformin—NDUFC2—digestive system—systemic scleroderma	0.00162	0.00348	CbGeAlD
Metformin—ND1—smooth muscle tissue—systemic scleroderma	0.00162	0.00347	CbGeAlD
Metformin—ND1—skin of body—systemic scleroderma	0.0016	0.00343	CbGeAlD
Metformin—NDUFS7—lung—systemic scleroderma	0.00157	0.00337	CbGeAlD
Metformin—NDUFS2—digestive system—systemic scleroderma	0.00156	0.00334	CbGeAlD
Metformin—NDUFC2—tendon—systemic scleroderma	0.00154	0.00331	CbGeAlD
Metformin—NDUFS3—digestive system—systemic scleroderma	0.00154	0.0033	CbGeAlD
Metformin—NDUFS2—tendon—systemic scleroderma	0.00148	0.00318	CbGeAlD
Metformin—NDUFS3—tendon—systemic scleroderma	0.00147	0.00314	CbGeAlD
Metformin—PRKAB1—lung—systemic scleroderma	0.00144	0.00308	CbGeAlD
Metformin—NDUFC2—lung—systemic scleroderma	0.00135	0.0029	CbGeAlD
Metformin—NDUFS2—lung—systemic scleroderma	0.0013	0.00279	CbGeAlD
Metformin—NDUFS3—lung—systemic scleroderma	0.00129	0.00276	CbGeAlD
Metformin—ND1—digestive system—systemic scleroderma	0.00128	0.00274	CbGeAlD
Metformin—ND1—lung—systemic scleroderma	0.00107	0.00229	CbGeAlD
Metformin—SLC22A2—digestive system—systemic scleroderma	0.00103	0.0022	CbGeAlD
Metformin—SLC22A3—connective tissue—systemic scleroderma	0.000959	0.00206	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—systemic scleroderma	0.000877	0.00188	CbGeAlD
Metformin—SLC47A1—digestive system—systemic scleroderma	0.000869	0.00186	CbGeAlD
Metformin—SLC47A1—tendon—systemic scleroderma	0.000827	0.00177	CbGeAlD
Metformin—SLC47A1—lung—systemic scleroderma	0.000725	0.00156	CbGeAlD
Metformin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000579	0.00108	CcSEcCtD
Metformin—SLC22A3—lung—systemic scleroderma	0.000578	0.00124	CbGeAlD
Metformin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000578	0.00108	CcSEcCtD
Metformin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000578	0.00108	CcSEcCtD
Metformin—Abdominal distension—Prednisone—systemic scleroderma	0.000574	0.00108	CcSEcCtD
Metformin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00108	CcSEcCtD
Metformin—Paraesthesia—Leflunomide—systemic scleroderma	0.000571	0.00107	CcSEcCtD
Metformin—Chest pain—Lisinopril—systemic scleroderma	0.00057	0.00107	CcSEcCtD
Metformin—Myalgia—Lisinopril—systemic scleroderma	0.00057	0.00107	CcSEcCtD
Metformin—Dyspnoea—Leflunomide—systemic scleroderma	0.000567	0.00106	CcSEcCtD
Metformin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000566	0.00106	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000566	0.00106	CcSEcCtD
Metformin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000564	0.00106	CcSEcCtD
Metformin—Discomfort—Lisinopril—systemic scleroderma	0.000563	0.00105	CcSEcCtD
Metformin—Lethargy—Methotrexate—systemic scleroderma	0.000563	0.00105	CcSEcCtD
Metformin—Dyspepsia—Leflunomide—systemic scleroderma	0.000559	0.00105	CcSEcCtD
Metformin—Pancreatitis—Prednisone—systemic scleroderma	0.000559	0.00105	CcSEcCtD
Metformin—Vomiting—Mometasone—systemic scleroderma	0.000558	0.00105	CcSEcCtD
Metformin—Sweating increased—Prednisone—systemic scleroderma	0.000556	0.00104	CcSEcCtD
Metformin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000555	0.00104	CcSEcCtD
Metformin—Rash—Mometasone—systemic scleroderma	0.000554	0.00104	CcSEcCtD
Metformin—Asthenia—Captopril—systemic scleroderma	0.000553	0.00104	CcSEcCtD
Metformin—Dermatitis—Mometasone—systemic scleroderma	0.000553	0.00104	CcSEcCtD
Metformin—Decreased appetite—Leflunomide—systemic scleroderma	0.000552	0.00104	CcSEcCtD
Metformin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000552	0.00103	CcSEcCtD
Metformin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00055	0.00103	CcSEcCtD
Metformin—Headache—Mometasone—systemic scleroderma	0.00055	0.00103	CcSEcCtD
Metformin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000549	0.00103	CcSEcCtD
Metformin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000549	0.00103	CcSEcCtD
Metformin—Fatigue—Leflunomide—systemic scleroderma	0.000548	0.00103	CcSEcCtD
Metformin—Oedema—Lisinopril—systemic scleroderma	0.000546	0.00102	CcSEcCtD
Metformin—Pruritus—Captopril—systemic scleroderma	0.000546	0.00102	CcSEcCtD
Metformin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000544	0.00102	CcSEcCtD
Metformin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000544	0.00102	CcSEcCtD
Metformin—Constipation—Leflunomide—systemic scleroderma	0.000543	0.00102	CcSEcCtD
Metformin—Infection—Lisinopril—systemic scleroderma	0.000542	0.00102	CcSEcCtD
Metformin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00054	0.00101	CcSEcCtD
Metformin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000539	0.00101	CcSEcCtD
Metformin—Shock—Lisinopril—systemic scleroderma	0.000537	0.00101	CcSEcCtD
Metformin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000535	0.001	CcSEcCtD
Metformin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000534	0.001	CcSEcCtD
Metformin—Neutropenia—Prednisone—systemic scleroderma	0.000533	0.000999	CcSEcCtD
Metformin—Abdominal pain—Azathioprine—systemic scleroderma	0.000532	0.000997	CcSEcCtD
Metformin—Skin disorder—Lisinopril—systemic scleroderma	0.00053	0.000994	CcSEcCtD
Metformin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000529	0.000991	CcSEcCtD
Metformin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000528	0.000989	CcSEcCtD
Metformin—Diarrhoea—Captopril—systemic scleroderma	0.000528	0.000988	CcSEcCtD
Metformin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000527	0.000987	CcSEcCtD
Metformin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000985	CcSEcCtD
Metformin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000524	0.000981	CcSEcCtD
Metformin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000523	0.000981	CcSEcCtD
Metformin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000523	0.000979	CcSEcCtD
Metformin—Nausea—Mometasone—systemic scleroderma	0.000521	0.000977	CcSEcCtD
Metformin—Anorexia—Lisinopril—systemic scleroderma	0.000521	0.000975	CcSEcCtD
Metformin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00052	0.000974	CcSEcCtD
Metformin—Constipation—Mycophenolic acid—systemic scleroderma	0.000518	0.000971	CcSEcCtD
Metformin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000518	0.000971	CcSEcCtD
Metformin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000515	0.000965	CcSEcCtD
Metformin—Hypotension—Lisinopril—systemic scleroderma	0.00051	0.000956	CcSEcCtD
Metformin—Dizziness—Captopril—systemic scleroderma	0.00051	0.000955	CcSEcCtD
Metformin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000509	0.000954	CcSEcCtD
Metformin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000948	CcSEcCtD
Metformin—Urticaria—Leflunomide—systemic scleroderma	0.000505	0.000946	CcSEcCtD
Metformin—Abdominal pain—Leflunomide—systemic scleroderma	0.000502	0.000941	CcSEcCtD
Metformin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0005	0.000936	CcSEcCtD
Metformin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000935	CcSEcCtD
Metformin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000935	CcSEcCtD
Metformin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000498	0.000934	CcSEcCtD
Metformin—Breast disorder—Methotrexate—systemic scleroderma	0.000498	0.000934	CcSEcCtD
Metformin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000498	0.000932	CcSEcCtD
Metformin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000496	0.000929	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000496	0.000929	CcSEcCtD
Metformin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000924	CcSEcCtD
Metformin—Paraesthesia—Lisinopril—systemic scleroderma	0.00049	0.000919	CcSEcCtD
Metformin—Vomiting—Captopril—systemic scleroderma	0.00049	0.000919	CcSEcCtD
Metformin—Dyspnoea—Lisinopril—systemic scleroderma	0.000487	0.000912	CcSEcCtD
Metformin—Rash—Captopril—systemic scleroderma	0.000486	0.000911	CcSEcCtD
Metformin—Dermatitis—Captopril—systemic scleroderma	0.000486	0.00091	CcSEcCtD
Metformin—Somnolence—Lisinopril—systemic scleroderma	0.000485	0.00091	CcSEcCtD
Metformin—Headache—Captopril—systemic scleroderma	0.000483	0.000905	CcSEcCtD
Metformin—Dyspepsia—Lisinopril—systemic scleroderma	0.000481	0.000901	CcSEcCtD
Metformin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000479	0.000898	CcSEcCtD
Metformin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000478	0.000896	CcSEcCtD
Metformin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000891	CcSEcCtD
Metformin—Decreased appetite—Lisinopril—systemic scleroderma	0.000475	0.000889	CcSEcCtD
Metformin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000471	0.000883	CcSEcCtD
Metformin—Fatigue—Lisinopril—systemic scleroderma	0.000471	0.000882	CcSEcCtD
Metformin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000471	0.000882	CcSEcCtD
Metformin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000879	CcSEcCtD
Metformin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000878	CcSEcCtD
Metformin—Pancreatitis—Methotrexate—systemic scleroderma	0.000467	0.000876	CcSEcCtD
Metformin—Constipation—Lisinopril—systemic scleroderma	0.000467	0.000875	CcSEcCtD
Metformin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000465	0.000871	CcSEcCtD
Metformin—Bradycardia—Prednisone—systemic scleroderma	0.000465	0.000871	CcSEcCtD
Metformin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000867	CcSEcCtD
Metformin—Diarrhoea—Azathioprine—systemic scleroderma	0.00046	0.000863	CcSEcCtD
Metformin—Nausea—Captopril—systemic scleroderma	0.000458	0.000858	CcSEcCtD
Metformin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000457	0.000856	CcSEcCtD
Metformin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000854	CcSEcCtD
Metformin—Asthenia—Leflunomide—systemic scleroderma	0.000456	0.000854	CcSEcCtD
Metformin—Feeling abnormal—Lisinopril—systemic scleroderma	0.00045	0.000843	CcSEcCtD
Metformin—Pruritus—Leflunomide—systemic scleroderma	0.00045	0.000842	CcSEcCtD
Metformin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000449	0.00084	CcSEcCtD
Metformin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000838	CcSEcCtD
Metformin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000447	0.000837	CcSEcCtD
Metformin—Neutropenia—Methotrexate—systemic scleroderma	0.000446	0.000835	CcSEcCtD
Metformin—Dizziness—Azathioprine—systemic scleroderma	0.000445	0.000834	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000443	0.00083	CcSEcCtD
Metformin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000817	CcSEcCtD
Metformin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000435	0.000815	CcSEcCtD
Metformin—Diarrhoea—Leflunomide—systemic scleroderma	0.000435	0.000815	CcSEcCtD
Metformin—Urticaria—Lisinopril—systemic scleroderma	0.000434	0.000813	CcSEcCtD
Metformin—Abdominal pain—Lisinopril—systemic scleroderma	0.000432	0.000809	CcSEcCtD
Metformin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00043	0.000805	CcSEcCtD
Metformin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000429	0.000804	CcSEcCtD
Metformin—Vomiting—Azathioprine—systemic scleroderma	0.000428	0.000802	CcSEcCtD
Metformin—Eye disorder—Prednisone—systemic scleroderma	0.000427	0.000799	CcSEcCtD
Metformin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000799	CcSEcCtD
Metformin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000797	CcSEcCtD
Metformin—Infestation—Methotrexate—systemic scleroderma	0.000425	0.000796	CcSEcCtD
Metformin—Drowsiness—Methotrexate—systemic scleroderma	0.000425	0.000796	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—systemic scleroderma	0.000425	0.000796	CcSEcCtD
Metformin—Rash—Azathioprine—systemic scleroderma	0.000424	0.000795	CcSEcCtD
Metformin—Dermatitis—Azathioprine—systemic scleroderma	0.000424	0.000794	CcSEcCtD
Metformin—Flushing—Prednisone—systemic scleroderma	0.000424	0.000794	CcSEcCtD
Metformin—Headache—Azathioprine—systemic scleroderma	0.000422	0.00079	CcSEcCtD
Metformin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000789	CcSEcCtD
Metformin—Dizziness—Leflunomide—systemic scleroderma	0.00042	0.000787	CcSEcCtD
Metformin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000416	0.000779	CcSEcCtD
Metformin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000415	0.000777	CcSEcCtD
Metformin—Angiopathy—Prednisone—systemic scleroderma	0.000414	0.000776	CcSEcCtD
Metformin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000774	CcSEcCtD
Metformin—Immune system disorder—Prednisone—systemic scleroderma	0.000412	0.000773	CcSEcCtD
Metformin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000767	CcSEcCtD
Metformin—Vomiting—Leflunomide—systemic scleroderma	0.000404	0.000757	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000402	0.000753	CcSEcCtD
Metformin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000401	0.000751	CcSEcCtD
Metformin—Rash—Leflunomide—systemic scleroderma	0.000401	0.000751	CcSEcCtD
Metformin—Dermatitis—Leflunomide—systemic scleroderma	0.0004	0.00075	CcSEcCtD
Metformin—Nausea—Azathioprine—systemic scleroderma	0.0004	0.000749	CcSEcCtD
Metformin—Headache—Leflunomide—systemic scleroderma	0.000398	0.000746	CcSEcCtD
Metformin—Malnutrition—Prednisone—systemic scleroderma	0.000397	0.000745	CcSEcCtD
Metformin—Erythema—Prednisone—systemic scleroderma	0.000397	0.000745	CcSEcCtD
Metformin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000394	0.000739	CcSEcCtD
Metformin—Asthenia—Lisinopril—systemic scleroderma	0.000392	0.000734	CcSEcCtD
Metformin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000733	CcSEcCtD
Metformin—Pruritus—Lisinopril—systemic scleroderma	0.000386	0.000724	CcSEcCtD
Metformin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000385	0.000722	CcSEcCtD
Metformin—Rash—Mycophenolic acid—systemic scleroderma	0.000382	0.000716	CcSEcCtD
Metformin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000382	0.000716	CcSEcCtD
Metformin—Hepatitis—Methotrexate—systemic scleroderma	0.000381	0.000715	CcSEcCtD
Metformin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000712	CcSEcCtD
Metformin—Headache—Mycophenolic acid—systemic scleroderma	0.00038	0.000712	CcSEcCtD
Metformin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000709	CcSEcCtD
Metformin—Nausea—Leflunomide—systemic scleroderma	0.000377	0.000707	CcSEcCtD
Metformin—Vision blurred—Prednisone—systemic scleroderma	0.000374	0.000702	CcSEcCtD
Metformin—Diarrhoea—Lisinopril—systemic scleroderma	0.000374	0.0007	CcSEcCtD
Metformin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000369	0.000691	CcSEcCtD
Metformin—Dizziness—Lisinopril—systemic scleroderma	0.000361	0.000677	CcSEcCtD
Metformin—Nausea—Mycophenolic acid—systemic scleroderma	0.00036	0.000675	CcSEcCtD
Metformin—Malaise—Prednisone—systemic scleroderma	0.000358	0.000671	CcSEcCtD
Metformin—Eye disorder—Methotrexate—systemic scleroderma	0.000357	0.000668	CcSEcCtD
Metformin—Syncope—Prednisone—systemic scleroderma	0.000356	0.000668	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000354	0.000663	CcSEcCtD
Metformin—Loss of consciousness—Prednisone—systemic scleroderma	0.000349	0.000654	CcSEcCtD
Metformin—Vomiting—Lisinopril—systemic scleroderma	0.000347	0.000651	CcSEcCtD
Metformin—Angiopathy—Methotrexate—systemic scleroderma	0.000346	0.000649	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—systemic scleroderma	0.000345	0.000646	CcSEcCtD
Metformin—Rash—Lisinopril—systemic scleroderma	0.000344	0.000645	CcSEcCtD
Metformin—Dermatitis—Lisinopril—systemic scleroderma	0.000344	0.000645	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000344	0.000644	CcSEcCtD
Metformin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000643	CcSEcCtD
Metformin—Hypertension—Prednisone—systemic scleroderma	0.000343	0.000643	CcSEcCtD
Metformin—Chills—Methotrexate—systemic scleroderma	0.000342	0.000641	CcSEcCtD
Metformin—Headache—Lisinopril—systemic scleroderma	0.000342	0.000641	CcSEcCtD
Metformin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000634	CcSEcCtD
Metformin—Myalgia—Prednisone—systemic scleroderma	0.000338	0.000634	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000336	0.00063	CcSEcCtD
Metformin—Discomfort—Prednisone—systemic scleroderma	0.000334	0.000626	CcSEcCtD
Metformin—Erythema—Methotrexate—systemic scleroderma	0.000332	0.000622	CcSEcCtD
Metformin—Malnutrition—Methotrexate—systemic scleroderma	0.000332	0.000622	CcSEcCtD
Metformin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000613	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—systemic scleroderma	0.000325	0.000609	CcSEcCtD
Metformin—Nausea—Lisinopril—systemic scleroderma	0.000324	0.000608	CcSEcCtD
Metformin—Oedema—Prednisone—systemic scleroderma	0.000324	0.000608	CcSEcCtD
Metformin—Infection—Prednisone—systemic scleroderma	0.000322	0.000604	CcSEcCtD
Metformin—Shock—Prednisone—systemic scleroderma	0.000319	0.000598	CcSEcCtD
Metformin—Nervous system disorder—Prednisone—systemic scleroderma	0.000318	0.000596	CcSEcCtD
Metformin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000593	CcSEcCtD
Metformin—Skin disorder—Prednisone—systemic scleroderma	0.000315	0.00059	CcSEcCtD
Metformin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000314	0.000587	CcSEcCtD
Metformin—Vision blurred—Methotrexate—systemic scleroderma	0.000313	0.000586	CcSEcCtD
Metformin—Anorexia—Prednisone—systemic scleroderma	0.000309	0.000579	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000308	0.000577	CcSEcCtD
Metformin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00057	CcSEcCtD
Metformin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000565	CcSEcCtD
Metformin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000565	CcSEcCtD
Metformin—Headache—Mycophenolate mofetil—systemic scleroderma	0.0003	0.000562	CcSEcCtD
Metformin—Malaise—Methotrexate—systemic scleroderma	0.000299	0.000561	CcSEcCtD
Metformin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000295	0.000554	CcSEcCtD
Metformin—Paraesthesia—Prednisone—systemic scleroderma	0.000291	0.000546	CcSEcCtD
Metformin—Dyspepsia—Prednisone—systemic scleroderma	0.000285	0.000535	CcSEcCtD
Metformin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000532	CcSEcCtD
Metformin—Chest pain—Methotrexate—systemic scleroderma	0.000283	0.00053	CcSEcCtD
Metformin—Myalgia—Methotrexate—systemic scleroderma	0.000283	0.00053	CcSEcCtD
Metformin—Decreased appetite—Prednisone—systemic scleroderma	0.000282	0.000528	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000281	0.000526	CcSEcCtD
Metformin—Fatigue—Prednisone—systemic scleroderma	0.00028	0.000524	CcSEcCtD
Metformin—Discomfort—Methotrexate—systemic scleroderma	0.000279	0.000523	CcSEcCtD
Metformin—Constipation—Prednisone—systemic scleroderma	0.000277	0.00052	CcSEcCtD
Metformin—Infection—Methotrexate—systemic scleroderma	0.000269	0.000505	CcSEcCtD
Metformin—Feeling abnormal—Prednisone—systemic scleroderma	0.000267	0.000501	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000266	0.000498	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000265	0.000497	CcSEcCtD
Metformin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000265	0.000497	CcSEcCtD
Metformin—Skin disorder—Methotrexate—systemic scleroderma	0.000263	0.000493	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000262	0.000491	CcSEcCtD
Metformin—Anorexia—Methotrexate—systemic scleroderma	0.000258	0.000484	CcSEcCtD
Metformin—Urticaria—Prednisone—systemic scleroderma	0.000258	0.000483	CcSEcCtD
Metformin—Abdominal pain—Prednisone—systemic scleroderma	0.000256	0.00048	CcSEcCtD
Metformin—Hypotension—Methotrexate—systemic scleroderma	0.000253	0.000475	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000247	0.000463	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—systemic scleroderma	0.000243	0.000456	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—systemic scleroderma	0.000242	0.000453	CcSEcCtD
Metformin—Somnolence—Methotrexate—systemic scleroderma	0.000241	0.000451	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—systemic scleroderma	0.000239	0.000447	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—systemic scleroderma	0.000236	0.000441	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000234	0.000438	CcSEcCtD
Metformin—Fatigue—Methotrexate—systemic scleroderma	0.000234	0.000438	CcSEcCtD
Metformin—Asthenia—Prednisone—systemic scleroderma	0.000233	0.000436	CcSEcCtD
Metformin—Pruritus—Prednisone—systemic scleroderma	0.000229	0.00043	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000223	0.000418	CcSEcCtD
Metformin—Diarrhoea—Prednisone—systemic scleroderma	0.000222	0.000416	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000222	0.000415	CcSEcCtD
Metformin—Urticaria—Methotrexate—systemic scleroderma	0.000215	0.000403	CcSEcCtD
Metformin—Dizziness—Prednisone—systemic scleroderma	0.000214	0.000402	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—systemic scleroderma	0.000214	0.000401	CcSEcCtD
Metformin—Vomiting—Prednisone—systemic scleroderma	0.000206	0.000386	CcSEcCtD
Metformin—Rash—Prednisone—systemic scleroderma	0.000204	0.000383	CcSEcCtD
Metformin—Dermatitis—Prednisone—systemic scleroderma	0.000204	0.000383	CcSEcCtD
Metformin—Headache—Prednisone—systemic scleroderma	0.000203	0.000381	CcSEcCtD
Metformin—Asthenia—Methotrexate—systemic scleroderma	0.000194	0.000364	CcSEcCtD
Metformin—Nausea—Prednisone—systemic scleroderma	0.000193	0.000361	CcSEcCtD
Metformin—Pruritus—Methotrexate—systemic scleroderma	0.000192	0.000359	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—systemic scleroderma	0.000185	0.000347	CcSEcCtD
Metformin—Dizziness—Methotrexate—systemic scleroderma	0.000179	0.000336	CcSEcCtD
Metformin—Vomiting—Methotrexate—systemic scleroderma	0.000172	0.000323	CcSEcCtD
Metformin—Rash—Methotrexate—systemic scleroderma	0.000171	0.00032	CcSEcCtD
Metformin—Dermatitis—Methotrexate—systemic scleroderma	0.000171	0.00032	CcSEcCtD
Metformin—Headache—Methotrexate—systemic scleroderma	0.00017	0.000318	CcSEcCtD
Metformin—Nausea—Methotrexate—systemic scleroderma	0.000161	0.000302	CcSEcCtD
